Sisi Li

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Lymphoblastic Leukemia

Inflammatory Response

Top Venues

Journal of inflammation research

Journal of drug targeting

Pediatric hematology and oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Dengming Lai, Kun Zhu, Sisi Li, Yi Xiao, Qi Xu, Yi-Sheng Sun, Pingping Yao, Daqing Ma, Qiang Shu
SARS-CoV-2 N Protein Triggers Acute Lung Injury via Modulating Macrophage Activation and Infiltration in in vitro and in vivo. Journal of inflammation research 16 (2023)
Dengming Lai, Kun Zhu, Sisi Li, Yi Xiao, Qi Xu, Yi-Sheng Sun, Pingping Yao, Daqing Ma, Qiang Shu
SARS-CoV-2 N Protein Triggers Acute Lung Injury via Modulating Macrophage Activation and Infiltration in in vitro and in vivo. Journal of inflammation research 16 (2023)
Dengming Lai, Kun Zhu, Sisi Li, Yi Xiao, Qi Xu, Yi-Sheng Sun, Pingping Yao, Daqing Ma, Qiang Shu
SARS-CoV-2 N Protein Triggers Acute Lung Injury via Modulating Macrophage Activation and Infiltration in in vitro and in vivo. Journal of inflammation research 16 (2023)
Sisi Li, Zhujun Wang, Xiaoping Guo, Ping Chen, Yong-Min Tang
Potent anti-tumor activity of CD45RA-targeting Hm3A4-Ranpirnase against myeloid lineage leukemias. Bioengineered 13 (4) (2022)
Meixin Fang, Hua Song, Jingying Zhang, Sisi Li, Diying Shen, Yongmin Tang
Efficacy and safety of immunosuppressive therapy with or without eltrombopag in pediatric patients with acquired aplastic anemia: A Chinese retrospective study. Pediatric hematology and oncology 38 (7) (2021)
Sisi Li, Hongqiang Shen, Qiang Shu
S3Ab, a novel antibody targeting B lymphocytes, is a potential therapeutic agent for B-lineage malignancies. Journal of drug targeting 27 (10) (2019)